Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Impact of broad-spectrum antibiotic exposure on outcomes following autologous stem cell transplantation for patients with relapsed diffuse large B-cell lymphoma or Hodgkin lymphoma

Mary Katherine Anderson, Valerie Shostrom, Robert Bociek, Snegha Ananth, Matthew Lunning, Julie Vose, Christopher D'Angelo

Blood (2025) 146 (Supplement 1): 8021.

https://doi.org/10.1182/blood-2025-8021

Published: 2025

Journal Articles

Frailty markers associated with impaired survival and hospitalization outcomes for patients with aggressive B-cell lymphoma receiving CAR T-cell therapy

Aaron Murray, Valerie Shostrom, Robert Bociek, Snegha Ananth, Julie Vose, Matthew Lunning, Tanya Wildes, Christopher D'Angelo

Blood (2025) 146 (Supplement 1): 785.

https://doi.org/10.1182/blood-2025-785

Published: 2025

Journal Articles

Patients with Private Insurance Endure Significantly Longer Delays in Time from Intent to CAR-T to Apheresis (Brain-2-Vein) in Multiple Treated Diffuse Large B-Cell Lymphoma: Analysis By Cellular Therapy Intent Quotient (CTIQ)

Matthew Gromowsky, Valerie Shostrom, Kimberly Schmidt-pokorny, James Olen Armitage, Julie M. Vose, Robert Gregory Bociek, Christopher D'Angelo, Matthew A Lunning

Blood (2023) 142 (Supplement 1): 258.

https://doi.org/10.1182/blood-2023-181344

Published: 2023

Journal Articles

Utilizing Y Chromosome FISH to Determine the Origin of Post-Transplant Lymphoproliferative Disease in Solid Organ Transplant Recipients

James B. Ford, DO, Sanmann N Jennifer, PhD, Kelly Erickson, Wendy J Grant, MD, Pamela A Althof, MS, Alan Langnas, Valerie Shostrom, Martin Bast, Timothy C. Greiner, MS, MD, Peter F. Coccia, MD

Blood (2018) 132 (Supplement 1): 5297.

https://doi.org/10.1182/blood-2018-99-119488

Published: 2018

Journal Articles

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Smith Giri, MBBS, Valerie Shostrom, MS, Krishna Gundabolu, MD, KM Monirul Islam, MDPhD, Ranjan Pathak, MD, Lori J. Maness, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 533.

https://doi.org/10.1182/blood.V126.23.533.533

Published: 2015

Journal Articles

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Roberto A. Ferro, MD, Valerie Shostrom, MS, Julie M. Vose, MD, Krishna Gundabolu, MD, Smith Giri, MBBS, KM Monirul Islam, MDPhD, Lori J. Maness, MD, James Olen Armitage, MD, Vijaya R. Bhatt, MD

Blood (2015) 126 (23): 268.

https://doi.org/10.1182/blood.V126.23.268.268

Published: 2015

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Impact of broad-spectrum antibiotic exposure on outcomes following autologous stem cell transplantation for patients with relapsed diffuse large B-cell lymphoma or Hodgkin lymphoma

Frailty markers associated with impaired survival and hospitalization outcomes for patients with aggressive B-cell lymphoma receiving CAR T-cell therapy

Patients with Private Insurance Endure Significantly Longer Delays in Time from Intent to CAR-T to Apheresis (Brain-2-Vein) in Multiple Treated Diffuse Large B-Cell Lymphoma: Analysis By Cellular Therapy Intent Quotient (CTIQ)

Utilizing Y Chromosome FISH to Determine the Origin of Post-Transplant Lymphoproliferative Disease in Solid Organ Transplant Recipients

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Email alerts

ASH Publications

American Society of Hematology

Update search

Impact of broad-spectrum antibiotic exposure on outcomes following autologous stem cell transplantation for patients with relapsed diffuse large B-cell lymphoma or Hodgkin lymphoma

Frailty markers associated with impaired survival and hospitalization outcomes for patients with aggressive B-cell lymphoma receiving CAR T-cell therapy

Patients with Private Insurance Endure Significantly Longer Delays in Time from Intent to CAR-T to Apheresis (Brain-2-Vein) in Multiple Treated Diffuse Large B-Cell Lymphoma: Analysis By Cellular Therapy Intent Quotient (CTIQ)

Utilizing Y Chromosome FISH to Determine the Origin of Post-Transplant Lymphoproliferative Disease in Solid Organ Transplant Recipients

Overall Survival (OS) of Acute Myeloid Leukemia (AML) Treated at Academic Center (AC) Versus Non-Academic Center (NAC)

Overall Survival (OS) of Acute Lymphoblastic Leukemia (ALL) Is Better When Initial Therapy Is Administered in Academic Hospitals (AH) Versus Non-Academic Hospitals (NAH): A Retrospective Analysis of the National Cancer Data Base (NCDB)

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only